Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Odia · SciRah

Researcher profile · Semantic Scholar

Y. Odia

Share profile

Y. Odia — researcher profile on SciRah

h-index: 26
Works: 207
Citations: 2,410

Most-cited papers

Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
S. Venneti, A. Kawakibi, Sunjong Ji, Sebastian M. Waszak +80 more
2023Cancer Discovery115 citations Open access
Semantic Scholar
Key Clinical Principles in the Management of Glioblastoma.
R. Kotecha, Y. Odia, A. Khosla, M. Ahluwalia
2023JCO Oncology Practice102 citations Open access
Semantic Scholar
ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma
I. Arrillaga-Romany, Sharon L. Gardner, Y. Odia, D. Aguilera +26 more
2024Journal of Clinical Oncology68 citations Open access
Semantic Scholar
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
Sharon L. Gardner, R. Tarapore, J. Allen, S. McGovern +17 more
2022Neuro-Oncology Advances55 citations Open access
Semantic Scholar
DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
Ahmad Ozair, V. Bhat, R. Alisch, A. Khosla +4 more
2023Cancers42 citations Open access
Semantic Scholar
Gabapentinoids confer survival benefit in human glioblastoma
J. Bernstock, Mulki Mehari, Jakob V. E. Gerstl, D. Meredith +34 more
2025Nature Communications25 citations Open access
Semantic Scholar
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial Design.
R. Kotecha, E. Akdemir, T. Kutuk, C. Ilgın +24 more
2025Neuro-Oncology23 citations Open access
Semantic Scholar
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma
Y. Odia, C. Koschmann, N. Vitanza, P. de Blank +17 more
2024Neuro-Oncology19 citations Open access
Semantic Scholar
Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases
R. Kotecha, R. Tonse, Miguel A. Ramirez Menendez, Andre Williams +9 more
2022Scientific Reports19 citations Open access
Semantic Scholar
Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience.
T. Kutuk, R. Tolakanahalli, V. Chaswal, Sreenija Yarlagadda +11 more
2023Brachytherapy15 citations
Semantic Scholar
Immunotherapy in Glioblastoma: An Overview of Current Status
Z. Sarfraz, Arun Maharaj, V. Venur, Justin D. Lathia +2 more
2025Clinical Pharmacology : Advances and Applications13 citations Open access
Semantic Scholar
Treatment of glioblastoma using MRIdian® A3i BrainTx™: Imaging and treatment workflow demonstration.
A. La Rosa, K. Mittauer, A. Rzepczynski, M. Chuong +13 more
2023Medical Dosimetry11 citations
Semantic Scholar
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort
Y. Odia, Matthew D. Hall, T. Cloughesy, P. Wen +6 more
2024Neuro-Oncology10 citations Open access
Semantic Scholar
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.
Michael R. Sargen, Jung Kim, T. Potjer, M. Velthuizen +18 more
2023JAMA dermatology10 citations Open access
Semantic Scholar
An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice.
E. Akdemir, Y. Odia, Matthew D. Hall, Minesh P. Mehta +1 more
2024Practical Radiation Oncology9 citations
Semantic Scholar
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis
T. Kutuk, Yanjia Zhang, E. Akdemir, Sreenija Yarlagadda +13 more
2024Journal of Neuro-Oncology8 citations
Semantic Scholar
Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
T. Kutuk, R. Tolakanahalli, N. McAllister, M. Hall +9 more
2022Cancers7 citations Open access
Semantic Scholar
Novel Therapies in Primary Central Nervous System Lymphoma
Michel Wakim, Mariana Mezher, A. Perez-Perez, Arun Maharaj +3 more
2025Clinical Pharmacology : Advances and Applications5 citations Open access
Semantic Scholar
Emerging therapies for glioblastoma
Z. Sarfraz, Tulika Ranjan, F. A. Mustafayev, M. Jaramillo +3 more
2025Journal of Neuro-Oncology5 citations
Semantic Scholar
Efficacy of 3D-TSE Sequence-based Radiosurgery in Prolonging Time to Distant Intracranial Failure: A Session-wise Analysis in a Histology-Diverse Patient Cohort.
E. Akdemir, S. Gurdikyan, M. Rubens, Kevin J. Abrams +14 more
2024Neuro-Oncology5 citations Open access
Semantic Scholar
A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE).
M. Ahluwalia, M. Ciesielski, D. Reardon, N. Butowski +16 more
2024Journal of Clinical Oncology5 citations Open access
Semantic Scholar
Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease
H. Appel, M. Rubens, Mukesh Roy, R. Kotecha +6 more
2024Neuro-Oncology Advances5 citations Open access
Semantic Scholar
Contrast-enhancing Lesions Induced by CNS-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes.
Omer Gal, Jen Yu, Minesh P. Mehta, Matthew D. Hall +7 more
2025International Journal of Radiation Oncology, Biology, Physics4 citations
Semantic Scholar
Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Disease: Real-World Feasibility, Toxicity, and Outcome Analysis
Omer Gal, A. La Rosa, Matthew D. Hall, R. Press +6 more
2025Cancers4 citations Open access
Semantic Scholar
Risk of radiation necrosis with concurrent antibody-drug conjugates and radiotherapy in HER2-positive breast cancer with brain metastases: A meta-analysis.
Z. Sarfraz, M. Ganiyani, F. N. Akkoc Mustafayev, K. Mustafayev +7 more
2025Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Efficacy and safety of dordaviprone (ONC201) in prospective clinical trials of adult and pediatric recurrent H3 K27M-mutant diffuse glioma patients.
A. Sumrall, J. Allen, Stephen J. Bagley, T. Brundage +14 more
2025Journal of Clinical Oncology4 citations
Semantic Scholar
CTNI-48. A PHASE 1 STUDY OF ERAS-801, A POTENT, SELECTIVE, AND CENTRAL NERVOUS SYSTEM (CNS)-PENETRANT EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR, FOR PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM)
P. Wen, M. Ahluwalia, Y. Odia, M. McKean +11 more
2024Neuro-Oncology3 citations Open access
Semantic Scholar
Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas.
Ryan Merrell, P. Wen, D. Forst, Jessica Schulte +6 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?
M. Bardhan, Debankur Dey, Vinay Suresh, Binish Javed +9 more
2023Expert Review of Neurotherapeutics3 citations
Semantic Scholar
P07.09.B A RANDOMIZED PHASE 2B STUDY OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)
M. Ahluwalia, M. Ciesielski, A. Abad, D. Reardon +17 more
2023Neuro-Oncology3 citations
Semantic Scholar
Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patients
E. Akdemir, S. Gurdikyan, T. C. Reyes, Y. Odia +13 more
2025Journal of Neuro-Oncology2 citations
Semantic Scholar
Prognostic Features of Recurrent Midline and H3 K27M-Mutant Glioma
Stephen J. Bagley, Y. Umemura, J. Mendez, I. Arrillaga-Romany +17 more
2025Cancers2 citations
Semantic Scholar
A pilot survey into the landscape of neuro-oncology care in the community
C. Lu-Emerson, S. Chowdhary, R. Kotecha, Akanksha Sharma +17 more
2025The Oncologist2 citations Open access
Semantic Scholar
Can targeting TSP-1 with gabapentin enhance survival in glioblastoma? A 20-year retrospective cohort study.
Mulki Mehari, Vardhaan S. Ambati, S. Krishna, Mikias Negussie +10 more
2024Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Rituximab Ibrutinib Lenalidomide (R2I) Combination for Primary or Secondary Large B-Cell CNS Lymphoma: Last Resort or Bridge to Cellular Therapy?
Ariel Perez Perez, Tiba Alsagheer, George Nahas, Muni Rubens +5 more
2023Blood2 citations Open access
Semantic Scholar
Evaluating the diagnostic performance of leptomeningeal diagnosis with CNSide compared to standard cytology.
H. Appel, Y. Odia, A. Saxena, Mukesh Roy +6 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas
A. La Rosa, A. Gutiérrez, Y. Odia, Michael W. McDermott +3 more
2023Neuro-Oncology Advances2 citations Open access
Semantic Scholar
Erratum to: Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
Y. Odia, A. Gutiérrez, R. Kotecha
2022Neuro-Oncology2 citations Open access
Semantic Scholar
SYST-07 WINDOW-OF-OPPORTUNITY STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND THALAMIC GLIOMA
Y. Odia, C. Koschmann, R. Tarapore, Jeffrey C. Allen +13 more
2022Neuro-Oncology Advances2 citations
Semantic Scholar
Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial
Z. Sarfraz, A. Ozair, M. Bardhan, A. Starosciak +10 more
2025BMC Cancer1 citations Open access
Semantic Scholar
Prognostic factors for brain metastasis in adolescent and young adult patients.
K. Mustafayev, F. N. Akkoc Mustafayev, Z. Sarfraz, L. Spiegelman +8 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
S. Venneti, A. Kawakibi, Sunjong Ji, Sebastian M. Waszak +80 more
2025Cancer Discovery1 citations Open access
Semantic Scholar
CTLT-04 SAFETY AND PRELIMINARY EVIDENCE OF A THERAPEUTIC EFFECT OF AZELIRAGON COMBINED WITH STEREOTACTIC RADIATION THERAPY IN PATIENTS WITH BRAIN METASTASES: PHASE 1 STUDY RESULTS
R. Kotecha, Y. Odia, Zhi-Jian Chen, A. Starosciak +8 more
2025Neuro-Oncology Advances1 citations Open access
Semantic Scholar
Advances in stem cell-based therapeutic transfers for glioblastoma treatment
M. Bardhan, M. Muneer, Abhinav Khare, Rushita Minesh Shah +7 more
2025Expert Review of Neurotherapeutics1 citations
Semantic Scholar
A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION).
R. Kotecha, Y. Odia, Zhi-Jian Chen, A. Starosciak +9 more
2024Journal of Clinical Oncology1 citations
Semantic Scholar
INNV-38. 3 DAYS-ON-1 DAY-OFF FRACTIONATED USE PROTOCOL FOR IMPROVED COMPLIANCE AND PREVENTATIVE SKIN SAFETY FOR USE OF TUMOR TREATING FIELDS: PRACTICE IMPROVEMENT STRATEGY IN NEURO-ONCOLOGY
Na Tosha N. Gatson, Erika Leese, Sara Ornelas, Ramya Tadipatri +3 more
2024Neuro-Oncology1 citations Open access
Semantic Scholar
CTIM-29. TUMOR RESPONSES IN A RANDOMIZED PHASE IIB TRIAL OF A CMV VACCINE IMMUNOTHERAPEUTIC CANDIDATE (VBI-1901) IN RECURRENT GLIOBLASTOMAS
Ryan Merrell, P. Wen, D. Forst, Jessica Schulte +8 more
2024Neuro-Oncology1 citations Open access
Semantic Scholar
Initial feasibility cohort of temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade intracranial malignancies
A. La Rosa, Z. Fellows, Andrew J. Wroe, L. Coutinho +12 more
2024Scientific Reports1 citations Open access
Semantic Scholar
TMET-02. CLINICAL EFFICACY OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IS DRIVEN BY DISRUPTION OF INTEGRATED METABOLIC AND EPIGENETIC PATHWAYS
S. Venneti, A. Kawakibi, Sunjong Ji, Sebastian M. Waszak +46 more
2023Neuro-Oncology1 citations Open access
Semantic Scholar
Tocilizumab, atezolizumab, and stereotactic radiotherapy in recurrent glioblastoma: primary analysis of safety and efficacy of a phase 2 trial, NRG Oncology-BN010.
Stephen J. Bagley, Mei-Yin C. Polley, R. Kotecha, Steven Brem +21 more
2026International Journal of Radiation Oncology, Biology, Physics0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Kotecha×24
Invite
R. Kotecha — researcher profile on SciRah
M. Ahluwalia×17
Invite
M. Ahluwalia — researcher profile on SciRah
Minesh P. Mehta×12
Invite
Minesh P. Mehta — researcher profile on SciRah
R. Tarapore×10
Invite
R. Tarapore — researcher profile on SciRah

×10

Invite

M. Mehta — researcher profile on SciRah

Invite

A. La Rosa — researcher profile on SciRah

Invite

S. Ramage — researcher profile on SciRah

Invite

M. Hall — researcher profile on SciRah

C. Koschmann×7

Invite

C. Koschmann — researcher profile on SciRah

M. Ahluwalia×7

Invite

M. Ahluwalia — researcher profile on SciRah

Invite

J. Allen — researcher profile on SciRah

Matthew D. Hall×7

Invite

Matthew D. Hall — researcher profile on SciRah